ENO1 and myelodysplastic syndrome: There were five patients with complex karyotypes (≥3 cytogenetic abnormalities), but there was no significant difference in circulating auto-ENO1 antibody levels between these patients and the rest of the MDS cohort (n = 21) (p = 0.4903).